transferrin receptor 2
Senast uppdaterad 18 aug 2020
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Den TFR2 gene provides instructions for making a protein called transferrin receptor 2. The main function of this protein is to help iron enter liver cells (hepatocytes). On the surface of hepatocytes, the receptor binds to a protein called transferrin, which transports iron through the blood to tissues throughout the body. When transferrin binds to transferrin receptor 2, iron is allowed to enter the cell.
Videoval för GenesVideobibliotek
Normal function
Den TFR2 gene provides instructions for making a protein called transferrin receptor 2. The main function of this protein is to help iron enter liver cells (hepatocytes). On the surface of hepatocytes, the receptor binds to a protein called transferrin, which transports iron through the blood to tissues throughout the body. When transferrin binds to transferrin receptor 2, iron is allowed to enter the cell.
Additionally, transferrin receptor 2 can bind to other proteins to help regulate iron storage levels in the body by controlling the levels of another protein called hepcidin. Hepcidin is a protein that determines how much iron is absorbed from the diet and released from storage sites in the body in response to iron levels.
Conditions referring to this gene or chromosome
Other names
HFE3
TFR2_HUMAN
Transferrin Receptor Protein 2
Related patient information and medicines

Patient information leaflet
Hemokromatos
Find out more here: [/health/haemochromatosis-leaflet](https://patient.info/health/haemochromatosis-leaflet) People with hemokromatos have. Excessive quantities of iron are then stored in various organs. Causes of haemochromatosis Haemochromatosis is a genetic condition. This can be done by having a blood test Blood tests.

Patient information leaflet
Mastocytos och mastcellssjukdomar
Triggers for mastocytosis symptoms Although not strictly speaking the cause of mastocytosis, a number of factors are known. If the condition is severe, surgery to remove ... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new.

Patient information leaflet
Diabetisk njursjukdom
En angiotensin-II receptor antagonist (AIIRA) There are several types and brands of this type of medication. ...candesartan Candesartan - an angiotensin receptor blocker , eprosartan Eprosartan - an angiotensin receptor blocker , irbesartan Irbesartan - an angiotensin receptor blocker , losartan Losartan - an angiotensin receptor blocker ,.

Patient information leaflet
Bröstcancer
Breast cancer stages How many breast cancer stages are there. Dr Sarah Jarvis MBE If left untreated, cancerformer often go through three stages: local growth, spread to lymph channels and spread to other areas of the body. For more information on the stages of cancer, go to.

Patient information leaflet
Kan jag ta kodein och morfin tillsammans?
Taking codeine and morphine together significantly increases the risk of serious side effects, including extreme sleepiness, dizziness, and dangerous breathing problems. Why this happens Both codeine and morphine work by attaching to the same receptors in the brain and spinal cord to block pain. Our Medicines Interaction Checker helps you check.

Patient information leaflet
Kan jag ta Bisoprolol och Trimbow tillsammans?
Bisoprolol and Trimbow (which contains formoterol) work in opposite ways on the airways. Bisoprolol may cause the airways to narrow, making it harder to breathe and potentially triggering asthma or COPD symptoms. It also makes the formoterol in the Trimbow inhaler less effective at opening your airways. Why this happens Bisoprolol is a.
Vidare läsning och referenser
- transferrin receptor 2; MedlinePlus, National Library of Medicine.
- Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000 May;25(1):14-5. doi: 10.1038/75534.
- Deicher R, Horl WH. New insights into the regulation of iron homeostasis. Eur J Clin Invest. 2006 May;36(5):301-9. doi: 10.1111/j.1365-2362.2006.01633.x.
- Gerhard GS, Paynton BV, DiStefano JK. Identification of Genes for Hereditary Hemochromatosis. Methods Mol Biol. 2018;1706:353-365. doi: 10.1007/978-1-4939-7471-9_19.
- Kleven MD, Jue S, Enns CA. Transferrin Receptors TfR1 and TfR2 Bind Transferrin through Differing Mechanisms. Biochemistry. 2018 Mar 6;57(9):1552-1559. doi: 10.1021/acs.biochem.8b00006. Epub 2018 Feb 12.
- Le Gac G, Mons F, Jacolot S, Scotet V, Ferec C, Frebourg T. Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descent. Br J Haematol. 2004 Jun;125(5):674-8. doi: 10.1111/j.1365-2141.2004.04950.x.
- Peters TM, Meulders AF, Redert K, Cuijpers ML, Rennings AJ, Janssen MC, Blijlevens NM, Swinkels DW. TFR2-related haemochromatosis in the Netherlands: a cause of arthralgia in young adulthood. Neth J Med. 2017 Mar;75(2):56-64.
- Pietrangelo A. Non-HFE hemochromatosis. Semin Liver Dis. 2005 Nov;25(4):450-60. doi: 10.1055/s-2005-923316.
- Roetto A, Daraio F, Alberti F, Porporato P, Cali A, De Gobbi M, Camaschella C. Hemochromatosis due to mutations in transferrin receptor 2. Blood Cells Mol Dis. 2002 Nov-Dec;29(3):465-70. doi: 10.1006/bcmd.2002.0585.
- Trinder D, Baker E. Transferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol. 2003 Mar;35(3):292-6. doi: 10.1016/s1357-2725(02)00258-3.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
18 aug 2020 | Senaste versionen
1 Oct 2006 | Ursprungligen publicerad
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

